Resonance Specialties Limited (BOM:524218)
India · Delayed Price · Currency is INR 138.45
-1.40 (-1.00%)
At close: Jun 19, 2026
Resonance Specialties Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 902.48 | 778.07 | 553.01 | 588.15 | 757.57 |
| 902.48 | 778.07 | 553.01 | 588.15 | 757.57 | |
Revenue Growth (YoY) | 15.99% | 40.70% | -5.97% | -22.36% | 6.86% |
Cost of Revenue | 563.35 | 495.33 | 356.28 | 334.69 | 446.69 |
Gross Profit | 339.13 | 282.73 | 196.73 | 253.46 | 310.88 |
Selling, General & Admin | 58.97 | 50.73 | 48.21 | 43.41 | 43.2 |
Other Operating Expenses | 140.08 | 124.2 | 100.38 | 141.83 | 100.17 |
Operating Expenses | 212.41 | 190.51 | 163.16 | 200 | 160.88 |
Operating Income | 126.72 | 92.22 | 33.57 | 53.46 | 150 |
Interest Expense | -2.41 | -3.48 | -3.27 | -0.33 | -0.15 |
Interest & Investment Income | - | 3.18 | 5.22 | 8.21 | 7.14 |
Currency Exchange Gain (Loss) | - | 3.86 | 3.84 | 7.04 | 4.31 |
Other Non Operating Income (Expenses) | 16.42 | 0.05 | 0.07 | 0.07 | 0.73 |
EBT Excluding Unusual Items | 140.74 | 95.82 | 39.43 | 68.44 | 162.03 |
Gain (Loss) on Sale of Investments | - | 2.72 | 0.1 | 0.01 | 0.74 |
Gain (Loss) on Sale of Assets | - | -1.85 | 0.1 | 0.06 | 0.03 |
Other Unusual Items | - | -7.91 | - | - | 0.08 |
Pretax Income | 140.74 | 88.78 | 39.64 | 68.51 | 162.87 |
Income Tax Expense | 36.78 | 23.12 | 9.95 | 18.5 | 39.27 |
Net Income | 103.96 | 65.66 | 29.68 | 50.01 | 123.6 |
Net Income to Common | 103.96 | 65.66 | 29.68 | 50.01 | 123.6 |
Net Income Growth | 58.32% | 121.20% | -40.65% | -59.54% | 17.44% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 |
Shares Change (YoY) | -0.05% | - | - | - | - |
EPS (Basic) | 9.01 | 5.69 | 2.57 | 4.33 | 10.71 |
EPS (Diluted) | 9.01 | 5.69 | 2.57 | 4.33 | 10.71 |
EPS Growth | 58.40% | 121.20% | -40.65% | -59.54% | 17.44% |
Free Cash Flow | 135.76 | -40.7 | -2.54 | -159.73 | 127.12 |
Free Cash Flow Per Share | 11.77 | -3.53 | -0.22 | -13.84 | 11.01 |
Dividend Per Share | 1.000 | 1.000 | - | 1.000 | 1.000 |
Gross Margin | 37.58% | 36.34% | 35.57% | 43.09% | 41.04% |
Operating Margin | 14.04% | 11.85% | 6.07% | 9.09% | 19.80% |
Profit Margin | 11.52% | 8.44% | 5.37% | 8.50% | 16.31% |
Free Cash Flow Margin | 15.04% | -5.23% | -0.46% | -27.16% | 16.78% |
EBITDA | 140.08 | 106.23 | 46.99 | 67.03 | 165.99 |
EBITDA Margin | 15.52% | 13.65% | 8.50% | 11.40% | 21.91% |
D&A For EBITDA | 13.36 | 14.01 | 13.42 | 13.58 | 15.99 |
EBIT | 126.72 | 92.22 | 33.57 | 53.46 | 150 |
EBIT Margin | 14.04% | 11.85% | 6.07% | 9.09% | 19.80% |
Effective Tax Rate | 26.13% | 26.04% | 25.11% | 27.00% | 24.11% |
Revenue as Reported | 918.89 | 787.87 | 562.34 | 604.27 | 771.06 |